Clinical Trial Update: Efficacy of 3% Hypertonic Saline in Acute Viral Bronchiolitis [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating the efficacy of 3% hypertonic saline for acute viral bronchiolitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Viral Bronchiolitis

Drugs mentioned

• 3% Hypertonic Saline (hypertonic saline (3%))

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Acute Viral Bronchiolitis | Phase 3 | Status: COMPLETED